[Congressional Record Volume 163, Number 6 (Tuesday, January 10, 2017)]
[Senate]
[Page S214]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 80. Mr. DURBIN (for himself and Ms. Klobuchar) submitted an 
amendment intended to be proposed by him to the concurrent resolution 
S. Con. Res. 3, setting forth the congressional budget for the United 
States Government for fiscal year 2017 and setting forth the 
appropriate budgetary levels for fiscal years 2018 through 2026; which 
was ordered to lie on the table; as follows:

       At the end of title IV, add the following:

     SEC. 4__. POINT OF ORDER AGAINST LEGISLATION THAT WOULD 
                   RESULT IN A REDUCTION OF FUNDING FOR BIOMEDICAL 
                   RESEARCH AGENCIES.

       (a) Point of Order.--It shall not be in order in the Senate 
     to consider any bill, joint resolution, motion, amendment, 
     amendment between the Houses, or conference report that would 
     result in a reduction of funding for the National Institutes 
     of Health, the Centers for Disease Control and Prevention, 
     the Defense Health Program, or the Medical and Prosthetics 
     Research Program of the Department of Veterans Affairs.
       (b) Waiver and Appeal.--Subsection (a) may be waived or 
     suspended in the Senate only by an affirmative vote of three-
     fifths of the Members, duly chosen and sworn. An affirmative 
     vote of three-fifths of the Members of the Senate, duly 
     chosen and sworn, shall be required to sustain an appeal of 
     the ruling of the Chair on a point of order raised under 
     subsection (a).
                                 ______